ARVN Q1 2019 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$856M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M-2.2% YoY

Gross Profit

$4M100.0% margin

Operating Income

-$16M-393.7% margin

Net Income

-$14M-358.6% margin

EPS (Diluted)

$-0.46

QoQ Revenue Growth

+16.8%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$187M

Total Liabilities

$59M

Stockholders' Equity

$128M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$4M	-2.2%
Gross Profit	$4M	$4M	-2.2%
Operating Income	-$16M	-$4M	-269.3%
Net Income	-$14M	-$4M	-247.1%